Export

EN
FR
Clofazimine
Essential medicine status
Section:
6. Anti-infective medicines 6.2. Antibacterials 6.2.5. Antituberculosis medicines
ATC codes: J04BA01
EMLc
Indication
Multi-drug resistant Mycobacterium tuberculosis ICD11 code: ML32.00
INN
Clofazimine
Medicine type
Chemical agent
List type
Core (EML)
(EMLc)
Additional notes
Reserve second-line drugs for the treatment of multidrug-resistant tuberculosis (MDR-TB) should be used in specialized centres adhering to WHO standards for TB control.
Formulations
Oral > Solid > dosage form: 100 mg ; 50 mg
EML status history
First added in 2017 (TRS 1006)
Changed in 2019 (TRS 1021)
Changed in 2025 (TRS 1064)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Wikipedia
Clofazimine
DrugBank
Clofazimine
Summary of evidence and Expert Committee recommendations
The Expert Committee recommended the transfer of listings for medicines for multi-drug resistant tuberculosis from the complementary to the core list of the EML and EMLc.